Nutex Health EV/EBIT NUTX
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2021.
- Today, Nov 2, 2026
- 3.3×
- 6-year median
- 12.6×
- Against its 6-year history
- 12th
- percentile: 0 is its lowest day, 100 its highest
- 6-year range
- 2.3× to 425×
- Peer median
- 26.7×
Nutex Health's EV/EBIT is 3.3× as of Nov 2, 2026.
That is below its 6-year median of 12.6×, lower than on 88% of days in the last 6 years.
Over that time it ranged from 2.3× in Sep 2025 to 425× in May 2022.
The median for 10 credit services stocks of a similar size is 26.7×.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.3× | 2.9× | 4.0× |
| 2025 | 2.9× | 2.3× | 14.3× |
| 2024 | 7.1× | 4.3× | 108× |
| 2023 | 4.8× | 3.4× | 26.5× |
| 2022 | 28.9× | 14.1× | 425× |
| 2021 | 19.2× | 16.3× | 255× |
Against its peers
Companies in Financial - Credit Services nearest Nutex Health's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| NUTXNutex Health | 3.3× |
| WDWalker & Dunlop | 26.7× |
| JCAPJefferson Capital | 8.4× |
| LQDTLiquidity Services | 26.8× |
| ATLCAtlanticus | 11.0× |
| PWPPerella Weinberg Partners | 94.9× |
| PGYPagaya Technologies | 3.4× |
| QNSTQuinstreet | 26.7× |
| RHLDResolute Holdings Management | 55.2× |
| HAPNHappen | n/m |
| MAXMediaAlpha | 11.8× |
| Peer median | 26.7× |
Where Nutex Health ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Nutex Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.